CN102575292B - 与疾病相关的kir单元型的测定 - Google Patents

与疾病相关的kir单元型的测定 Download PDF

Info

Publication number
CN102575292B
CN102575292B CN201080042050.6A CN201080042050A CN102575292B CN 102575292 B CN102575292 B CN 102575292B CN 201080042050 A CN201080042050 A CN 201080042050A CN 102575292 B CN102575292 B CN 102575292B
Authority
CN
China
Prior art keywords
kir
primer
individuality
allelotrope
amplicon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201080042050.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN102575292A (zh
Inventor
G.本特利
H.A.埃尔利希
D.古德里奇
M.拉德纳
E.特拉赫特滕伯格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Konesio Gene Technology Private Ltd.
Illumina Inc
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN102575292A publication Critical patent/CN102575292A/zh
Application granted granted Critical
Publication of CN102575292B publication Critical patent/CN102575292B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201080042050.6A 2009-09-22 2010-09-17 与疾病相关的kir单元型的测定 Active CN102575292B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24482109P 2009-09-22 2009-09-22
US61/244821 2009-09-22
PCT/EP2010/005721 WO2011035870A1 (en) 2009-09-22 2010-09-17 Determination of kir haplotypes associated with disease

Publications (2)

Publication Number Publication Date
CN102575292A CN102575292A (zh) 2012-07-11
CN102575292B true CN102575292B (zh) 2015-07-29

Family

ID=43302366

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080042050.6A Active CN102575292B (zh) 2009-09-22 2010-09-17 与疾病相关的kir单元型的测定

Country Status (7)

Country Link
US (2) US9005894B2 (de)
EP (1) EP2480683B1 (de)
JP (1) JP5926183B2 (de)
CN (1) CN102575292B (de)
CA (1) CA2770143C (de)
ES (1) ES2661055T3 (de)
WO (1) WO2011035870A1 (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
EP4335932A3 (de) 2008-11-07 2024-06-26 Adaptive Biotechnologies Corporation Verfahren zur überwachung von zuständen durch sequenzanalyse
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US8685898B2 (en) 2009-01-15 2014-04-01 Imdaptive, Inc. Adaptive immunity profiling and methods for generation of monoclonal antibodies
CA2765949C (en) 2009-06-25 2016-03-29 Fred Hutchinson Cancer Research Center Method of measuring adaptive immunity
US9005894B2 (en) 2009-09-22 2015-04-14 Roche Molecular Systems, Inc. Determination of KIR haplotypes associated with disease
EP2854057B1 (de) 2010-05-18 2018-03-07 Natera, Inc. Verfahren zur nichtinvasiven pränatalen Ploidiezuordnung
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
JP6153874B2 (ja) 2011-02-09 2017-06-28 ナテラ， インコーポレイテッド 非侵襲的出生前倍数性呼び出しのための方法
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
US9279159B2 (en) 2011-10-21 2016-03-08 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
EP2788509B1 (de) 2011-12-09 2018-07-11 Adaptive Biotechnologies Corporation Diagnose von lymphoid-malignität und nachweis minimaler resterkrankungen
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
WO2013134162A2 (en) 2012-03-05 2013-09-12 Sequenta, Inc. Determining paired immune receptor chains from frequency matched subunits
SG10201507700VA (en) 2012-05-08 2015-10-29 Adaptive Biotechnologies Corp Compositions and method for measuring and calibrating amplification bias in multiplexed pcr reactions
EP2861761A1 (de) * 2012-06-15 2015-04-22 Adaptive Biotechnologies Corporation Eindeutig markierte adaptive neuangeordnete immunrezeptorgene in einem komplexen genset
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
ES2660027T3 (es) 2012-10-01 2018-03-20 Adaptive Biotechnologies Corporation Evaluación de la inmunocompetencia por la diversidad de los receptores de inmunidad adaptativa y caracterización de la clonalidad
ES2480840B1 (es) * 2012-12-28 2015-07-07 Universidad de Córdoba Método de obtención de datos útiles para predecir la respuesta al tratamiento de la Hepatitis C
WO2014120949A1 (en) * 2013-01-30 2014-08-07 Memorial Sloan-Kettering Cancer Center Donor kir3dl1 and hla-b subtypes and leukemia control in hla-compatible allogenic hematopoietic stem cell transplantation
EP2973373A4 (de) * 2013-03-15 2016-11-09 Sloan Kettering Inst Cancer Verfahren und algorithmus zur auswahl eines allogenen hämatopoetischen zellenspenders auf der basis von kir- und hla-genotypen
JP2016512682A (ja) * 2013-03-15 2016-05-09 メモリアル スローン−ケタリング キャンサー センター Ｋｉｒ３ｄｌ１対立遺伝子分類キット及び方法
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
CN103540672B (zh) * 2013-10-29 2015-04-08 中国科学技术大学 一种亲和核酸分子的快速鉴定和分离方法
WO2015134787A2 (en) 2014-03-05 2015-09-11 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
ES2777529T3 (es) 2014-04-17 2020-08-05 Adaptive Biotechnologies Corp Cuantificación de genomas de células inmunitarias adaptativas en una mezcla compleja de células
CN106460070B (zh) 2014-04-21 2021-10-08 纳特拉公司 检测染色体片段中的突变和倍性
US9745611B2 (en) * 2014-05-06 2017-08-29 Genewiz Inc. Methods and kits for identifying microorganisms in a sample
EP3715455A1 (de) 2014-10-29 2020-09-30 Adaptive Biotechnologies Corp. Hochmultiplexierter gleichzeitiger nachweis von für adaptive gepaarte immunrezeptorheterodimere codierenden nukleinsäuren aus einer vielzahl von proben
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
US11066705B2 (en) 2014-11-25 2021-07-20 Adaptive Biotechnologies Corporation Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
EP3591074B1 (de) 2015-02-24 2024-10-23 Adaptive Biotechnologies Corp. Verfahren zur diagnose einer infektionskrankheit und bestimmung des hla-status mittels immunrepertoiresequenzierung
EP3277294B1 (de) 2015-04-01 2024-05-15 Adaptive Biotechnologies Corp. Verfahren zur identifizierung von menschlichen kompatiblen t-zell-rezeptoren spezifisch für ein antigen-ziel
EP4428863A2 (de) 2015-05-11 2024-09-11 Natera, Inc. Verfahren und zusammensetzungen zur bestimmung der ploidie
EP3106876B1 (de) 2015-06-19 2022-12-07 F. Hoffmann-La Roche AG Feststoffabfallentsorgung
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
US11453908B2 (en) 2016-10-01 2022-09-27 Memorial Sloan Kettering Cancer Center Methods and kits for typing KIR2DL alleles
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
CN107058544B (zh) * 2017-04-25 2018-03-20 深圳市血液中心 14个功能性杀伤细胞免疫球蛋白样受体KIRs基因同步测序分型的方法
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
US12084720B2 (en) 2017-12-14 2024-09-10 Natera, Inc. Assessing graft suitability for transplantation
CA3090426A1 (en) 2018-04-14 2019-10-17 Natera, Inc. Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna
US11525159B2 (en) 2018-07-03 2022-12-13 Natera, Inc. Methods for detection of donor-derived cell-free DNA
CN109486963B (zh) * 2018-11-29 2021-10-22 江苏中济万泰生物医药有限公司 一种人类kir基因分型检测引物组及应用
CN112725428A (zh) * 2021-02-22 2021-04-30 深圳荻硕贝肯精准医学有限公司 Kir2dl4基因分型试剂盒和分型方法
CN112746099A (zh) * 2021-02-22 2021-05-04 深圳荻硕贝肯精准医学有限公司 Kir2ds4基因分型试剂盒和分型方法
CN112708667A (zh) * 2021-02-22 2021-04-27 深圳荻硕贝肯精准医学有限公司 Kir3ds1基因分型试剂盒和分型方法
CN112746100A (zh) * 2021-03-05 2021-05-04 深圳荻硕贝肯精准医学有限公司 用于kir基因分型的引物、试剂盒及方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007041067A2 (en) * 2005-09-29 2007-04-12 Children's Hospital & Research Center At Oakland Methods and compositions for kir genotyping
WO2009049889A1 (en) * 2007-10-16 2009-04-23 Roche Diagnostics Gmbh High resolution, high throughput hla genotyping by clonal sequencing
WO2009051672A2 (en) * 2007-10-12 2009-04-23 St. Jude Children's Research Hospital Natural killer immunoglobulin-like receptor (kir) assay

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620209D0 (en) 1996-09-27 1996-11-13 Cemu Bioteknik Ab Method of sequencing DNA
GB9626815D0 (en) 1996-12-23 1997-02-12 Cemu Bioteknik Ab Method of sequencing DNA
US6274320B1 (en) 1999-09-16 2001-08-14 Curagen Corporation Method of sequencing a nucleic acid
WO2005046459A2 (en) * 2003-10-22 2005-05-26 Pel-Freez Clinical Systems, Inc. Primers, methods and kits for detecting killer-cell immunoglobulin-like receptor alleles
US20100086914A1 (en) * 2008-10-03 2010-04-08 Roche Molecular Systems, Inc. High resolution, high throughput hla genotyping by clonal sequencing
GB0724131D0 (en) * 2007-12-11 2008-01-23 Uutech Ltd Use of KIR genes for predicting response to therapy
US9005894B2 (en) 2009-09-22 2015-04-14 Roche Molecular Systems, Inc. Determination of KIR haplotypes associated with disease

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007041067A2 (en) * 2005-09-29 2007-04-12 Children's Hospital & Research Center At Oakland Methods and compositions for kir genotyping
WO2009051672A2 (en) * 2007-10-12 2009-04-23 St. Jude Children's Research Hospital Natural killer immunoglobulin-like receptor (kir) assay
WO2009049889A1 (en) * 2007-10-16 2009-04-23 Roche Diagnostics Gmbh High resolution, high throughput hla genotyping by clonal sequencing

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
上海地区汉族人群杀伤细胞免疫球蛋白样受体基因多样性及单倍型组合研究;张磊等;《中华医学遗传学杂志》;20031026(第05期);396-399 *
人类杀伤细胞免疫球蛋白样受体基因PCR-SSP分型方法的建立及其应用;姜侃等;《中华微生物学和免疫学杂志》;20051228(第12期);1044-1048 *

Also Published As

Publication number Publication date
CN102575292A (zh) 2012-07-11
EP2480683B1 (de) 2017-11-29
EP2480683A1 (de) 2012-08-01
US9005894B2 (en) 2015-04-14
US9914970B2 (en) 2018-03-13
JP5926183B2 (ja) 2016-05-25
WO2011035870A1 (en) 2011-03-31
ES2661055T3 (es) 2018-03-27
CA2770143A1 (en) 2011-03-31
ES2661055T8 (es) 2023-04-11
CA2770143C (en) 2015-11-03
JP2013505027A (ja) 2013-02-14
US20150184243A1 (en) 2015-07-02
US20110129830A1 (en) 2011-06-02

Similar Documents

Publication Publication Date Title
CN102575292B (zh) 与疾病相关的kir单元型的测定
CA2853088C (en) Quantification of adaptive immune cell genomes in a complex mixture of cells
ES2703764T3 (es) Biomarcadores personalizados para el cáncer
EP3075863B1 (de) Einfaches verfahren und kit zur dna-profilierung von hla-genen mit massiv-parallelem hochdurchsatz-sequenzer
CN104603287A (zh) 用于测定核苷酸序列的方法
EP3455375B1 (de) Nachweis von met-exon-14-deletionen
CN103534591A (zh) 通过测序分析进行的非侵入性胎儿遗传筛选
WO2014180905A1 (en) Non-invasive early detection of solid organ transplant rejection by quantitative analysis of mixtures by deep sequencing of hla gene amplicons using next generation systems
EP3775274B1 (de) Verfahren zum nachweis von somatischen genetischen anomalien, kombination von fangsonden und nachweiskit
Zhang et al. Effector CD4+ T cell expression signatures and immune-mediated disease associated genes
US20170327868A1 (en) Blocker based enrichment system and uses thereof
US20200232033A1 (en) Platform independent haplotype identification and use in ultrasensitive dna detection
WO2019183582A9 (en) Immune repertoire monitoring
JP2021505143A (ja) 多血小板血漿サンプルからの核酸の検出
JP2022187310A (ja) 膵がん化学療法における副作用発生リスクの予測を補助する方法
WO2020033238A1 (en) A non-invasive prenatal test with accurate fetal fraction measurement
US20220136042A1 (en) Improved nucleic acid target enrichment and related methods
US20140302013A1 (en) Predicting and diagnosing patients with systemic lupus erythematosus
Zhang et al. The novel HLA‐B allele, HLA‐B* 50: 31, was identified by sequencing genomic DNA.
Jin et al. Identification of a novel HLA-A* 02 allele, HLA-A* 02: 432, in a Chinese individual.
WO2024200616A1 (en) Novel assay for phasing of distant genomic loci with zygosity resolution via long-read sequencing hybrid data analysis
WO2023097197A2 (en) Compositions and methods for assessing the efficacy of polynucleotide delivery and cancer therapy
WO2020185781A1 (en) Microrna regulatory network as biomarkers of seizure in patients with spontaneous intracerebral hemorrhage
Yang et al. • HLA-DQB1 Genotyping with Simple Automated DNA Sequencing and Single-Strand Conformation Polymorphism Analysis
Waziri et al. Immune Gene and Cell Enrichment Is Associated

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20230418

Address after: California, USA

Patentee after: ILLUMINA, Inc.

Address before: Freeman o, Australia

Patentee before: Konesio Gene Technology Private Ltd.

Effective date of registration: 20230418

Address after: Freeman o, Australia

Patentee after: Konesio Gene Technology Private Ltd.

Address before: Basel, SUI

Patentee before: Hoffman-La Roche Ltd.

TR01 Transfer of patent right